Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ID Cap System: Next Generation Ingestible Sensors for Medication Adherence Measurement

NCT05592613 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05592613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05592613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ID Cap System: Next Generation Ingestible Sensors for Medication Adherence Measurement
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 6, 2023
Completion date
July 25, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, medication, adherence, treatment, antiretroviral therapy, hiv infection, pre-exposure prophylaxis